August 9th, 2017

We are proud that the Nifuroxazide polymorph screening case-study performed in-house by SARA Pharm was recently published in CrystEngComm: http://pubs.rsc.org/en/content/articlelanding/2017/ce/c7ce00303j#!divAbstract.